Article Details
Retrieved on: 2024-08-19 14:35:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The trials included 5 groups of interventions: BTKi, PI3K inhibitors (PI3Ki), BCL2 antagonists, anti-CD20 monoclonal antibodies, and other therapies.
Article found on: www.ajmc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here